Feed Preview

Fast Growing

Graft Rejection

Graft Rejection diagram by StudioMolekuul, Shutterstock
StudioMolekuul, Shutterstock

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

Top 20 most recent papers
Nature

Metabolites released from apoptotic cells act as tissue messengers

NatureApril 3, 2020
Christopher B MedinaKodi S Ravichandran
317
3
1
1
2
Journal of Psychosomatic Research

Beliefs about immunosuppressant medication and correlates in a German kidney transplant population

Journal of Psychosomatic ResearchMarch 11, 2020
Maybrit BünemannMariel Nöhre
Progress in Transplantation : Official Publication, North American Transplant Coordinators Organization ... [et Al.]

The Etiology and Prognosis of Delayed Postoperative Leukocytosis in Lung Transplant Recipients

Progress in Transplantation : Official Publication, North American Transplant Coordinators Organization ... [et Al.]April 3, 2020
Shimon IzhakianMordechai R Kramer
Boletín médico del Hospital Infantil de México

Pediatric penetrating keratoplasty and graft rejection: experience at the Hospital Infantil de México Federico Gómez

Boletín médico del Hospital Infantil de MéxicoMarch 3, 2020
Karen Velásquez-MonzónMarco A Ramírez-Ortiz
Therapeutic Advances in Ophthalmology

Approaches toward enhancing survival probability following deep anterior lamellar keratoplasty

Therapeutic Advances in OphthalmologyApril 2, 2020
Sepehr Feizi, Amir A Azari
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Does mucosal inflammation drive recurrence of primary sclerosing cholangitis in liver transplantion recipients with ulcerative colitis?

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the LiverMarch 10, 2020
Nik DekkersJeroen Maljaars
European Journal of Ophthalmology

Epithelial downgrowth after Descemet membrane endothelial keratoplasty

European Journal of OphthalmologyMarch 13, 2020
Viet Nhat Hung LeClaus Cursiefen
Omics : a Journal of Integrative Biology

A Noninvasive Urine Metabolome Panel as Potential Biomarkers for Diagnosis of T Cell-Mediated Renal Transplant Rejection

Omics : a Journal of Integrative BiologyMarch 17, 2020
Shiva KalantariNooshin Dalili
Clinical & Translational Immunology

Regulatory T cells in solid organ transplantation

Clinical & Translational ImmunologyFebruary 28, 2020
Muhammad AtifMakoto Miyara
Free Radical Biology & Medicine

Heme Oxygenase-1 in liver transplant ischemia-reperfusion injury: From bench-to-bedside

Free Radical Biology & MedicineFebruary 22, 2020
Hirofumi HiraoJerzy W Kupiec-Weglinski
3

See more papers from this feed

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Exosomes & Tumor Environment

Several studies have reported the role of exosomes as important mediators of angiogenesis, metastasis, and immune modulation. Exosomes also have the potential to be used as biomarkers for clinical predictions. Here is the latest research on exosomes and the tumor microenvironment.

Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.


Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Immuno-Oncology

Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.

Immunosuppression

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Tumor Evasion of the Immune System

Tumor evasion of the immune system includes cells that operate their own growth and develop various strategies to escape from immune surveillance. Discover the latest research on tumor evasion of the immune system here.

Tumor Vaccines

Tumor vaccines offer the potential for preventing cancer in high-risk individuals, preventing disease relapse after diagnosis and initial therapy, and shifting the balance of the host-tumor interaction to mitigate the progression of advanced cancers. Discover the latest research on tumor vaccines here.

© 2020 Meta ULC. All rights reserved
/feed-previews/graft-rejection/cce2dbb5-a5f0-444e-b673-14ce44d8820e